Molecular classification of breast carcinomas using tissue microarrays.
about
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedA systems approach to clinical oncology: focus on breast cancer.Proteomics of breast cancer: principles and potential clinical applications.Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR studyMeta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesClinical proteomics of breast cancerNuclear CSPP1 expression defined subtypes of basal-like breast cancer.St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarraysMinichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerGenome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.The pathology of hereditary breast cancer.Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancerp53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women.Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancerTissue microarrays: bridging the gap between research and the clinic.Immunoprofile from tissue microarrays to stratify familial breast cancer patientsA new genome-driven integrated classification of breast cancer and its implications.Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer.Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.PathGrid: a service-orientated architecture for microscopy image analysis.Regulation of iron homeostasis by the p53-ISCU pathway.Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.Identification and validation of an ERBB2 gene expression signature in breast cancers.Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial.An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.Basal markers and prognosis in luminal breast cancer.
P2860
Q24610409-90B5F494-5986-49A8-9CCB-5A7B4BAD600DQ33238889-A263CBCE-1ECE-48A6-88AC-2B4A9CE5CF34Q33245053-17E31642-6961-40F9-AD60-ED8051C6F1F9Q33251551-9D72882A-F8B2-4DEA-BB1D-E33FAC69B8F4Q33276929-EA259C58-D6EB-4180-B062-36496A3B8E3CQ33338630-A4194CD0-500A-46AC-9462-D7F0810C9E4CQ33593016-753E6B91-7CBE-4D52-AC1B-45761AF8C577Q33885885-8C22B790-334D-4CCC-B9CF-B00819AB4889Q33918128-2BE0CA51-AFFD-430E-982C-2304F0B23531Q34463987-2412D4E3-98BC-4FF8-8CC2-223828F28B28Q34466187-82AD2BCE-5488-4D12-BA2F-A972611D99DAQ35074445-9EE5D7C9-C9A3-4626-A232-1E21621E8CAEQ35097632-7100C279-59F1-483C-AC5D-07F91FA945EEQ35355084-859EA4B2-1F7C-410B-8F8C-ADBC13CFBF6DQ35591546-241892EE-09C5-45DE-BC12-DD2908694A1DQ36001510-8D5FBD76-E4EC-4197-86B4-2C3495AF303BQ36107330-B761AE48-3AC2-4B93-9686-B8B87EEBC0E2Q36163073-5FB93718-3B1B-48E1-B1F6-D767AEB5578AQ36180689-AEC82A14-8B91-41B9-ACBD-048D1D0B9E38Q36184792-52B04C83-5955-404D-8E0F-C29544C1D2ABQ36413928-D82D9D43-FC6A-473B-AE0F-833BD75938C2Q36664694-4993D087-3C42-4896-BB1A-710B1ED88092Q36671817-42336480-769A-4438-99F4-85D6D1662F2DQ36873822-EDBE1D49-EAD9-4521-85F7-904A833B62E1Q36908377-045DCC95-E0D3-4F41-A8E3-97415EDA2B1FQ36973076-C40AE130-C7B3-4030-904C-7A7CF88D741EQ37137019-1B079BE6-71CB-4279-B348-C6567B2884B7Q37290523-504F9BF7-FE49-4BBA-A47F-AB15E15AF613Q37330694-3D7CB9F7-C9F0-4B8D-9C78-1D8071580F65Q37401549-41D696BD-93BB-49AF-9183-563FC4279E6EQ37681710-971929DA-D04C-4096-B662-9FC504A86032Q38428392-83112BAB-474E-43EE-918E-17DB7C19CA5FQ38820048-636B9D7F-55E3-4581-8991-255DACC2708CQ39974519-ED0D3B9A-033E-44FA-A329-12DE22E5DC6BQ40595739-375183B0-1065-4753-9CF1-574766D73EF5Q42435532-06D39AC2-42CA-4F10-92D9-8DF8DF008339Q42473072-9052F21E-6E20-407C-9B32-C9E4068D91A7Q42497579-D9E1E3DD-8C4F-41CF-9D6E-637BF8E15300Q42505879-207DF287-BB7B-4E25-A538-2C2E8B05D5ACQ42506475-7F5B875A-6987-4D62-BE9A-75951BA8A772
P2860
Molecular classification of breast carcinomas using tissue microarrays.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular classification of breast carcinomas using tissue microarrays.
@ast
Molecular classification of breast carcinomas using tissue microarrays.
@en
type
label
Molecular classification of breast carcinomas using tissue microarrays.
@ast
Molecular classification of breast carcinomas using tissue microarrays.
@en
prefLabel
Molecular classification of breast carcinomas using tissue microarrays.
@ast
Molecular classification of breast carcinomas using tissue microarrays.
@en
P2093
P50
P1476
Molecular classification of breast carcinomas using tissue microarrays.
@en
P2093
Grace Callagy
Lisa Happerfield
Lynda G Bobrow
Yataro Daigo
P356
10.1097/00019606-200303000-00004
P577
2003-03-01T00:00:00Z